⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHAT News
Phathom Pharmaceuticals, Inc. Common Stock
Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)
globenewswire.com
PHAT
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
globenewswire.com
PHAT
Form 8-K
sec.gov
PHAT
Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting
globenewswire.com
PHAT
Philatron Delivers Shorter Lead Times Through U.S. Manufacturing
prnewswire.com
PHAT
Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting
globenewswire.com
PHAT
Form 8-K
sec.gov
PHAT
Phathom Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
PHAT
Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026
globenewswire.com
PHAT
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
globenewswire.com
PHAT